AliveCor QT Service vs prolaio eVO2peak Module

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AliveCor QT Service

by AliveCor

prolaio eVO2peak Module

by Prolaio

AI Verdict

These tools are adjacent rather than direct competitors, as they address different aspects of cardiovascular health. Tool A focuses on cardiac safety by providing instant QT/QTc interval measurements from specific ECG devices, primarily for informing medication prescribing decisions. In contrast, Tool B estimates peak oxygen consumption (eVO2peak) using diverse real-world patient data from third-party wearable sensors, serving as an adjunctive aid in cardiovascular research and clinical evaluation.

Choose AliveCor QT Service if…

Choose AliveCor QT Service if your primary need is instant and accurate QT/QTc interval measurement from AliveCor 6-Lead ECGs to assess cardiac safety. This tool is ideal for healthcare professionals who need to quickly inform medication prescribing decisions and monitor for potential drug-induced QT prolongation.

View AliveCor QT Service →

Choose prolaio eVO2peak Module if…

Choose prolaio eVO2peak Module if you require an FDA-cleared solution to estimate peak oxygen consumption (eVO2peak) using real-world patient data from wearable sensors. This is particularly useful for cardiovascular research, longitudinal monitoring of patient fitness, and as an adjunctive aid in clinical evaluation where VO2peak is a key indicator.

View prolaio eVO2peak Module →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AliveCor QT Service	prolaio eVO2peak Module
Pricing	Varies by product and service, with subscription options available.	Contact for pricing
Deployment	Mobile app, cloud-based platform, EHR integration.	Cloud-based (software-only, processes remote sensor data)
BAA Available	Yes AI-estimated	Unknown
FDA Status	1 AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AliveCor QT Service

AliveCor QT Service benefits from a tightly integrated ecosystem with its widely adopted KardiaMobile devices and KardiaPro portal, suggesting a more streamlined and user-friendly experience for data acquisition and analysis. Tool B's reliance on various third-party sensors, while offering flexibility, could potentially introduce greater complexity in setup and data aggregation for the user.

Clinical Value

Tie

Both tools offer significant and distinct clinical value. AliveCor QT Service addresses immediate cardiac safety concerns related to medication, while prolaio eVO2peak Module provides a powerful prognostic indicator for long-term cardiovascular health and risk assessment. The 'value' depends heavily on the specific clinical context and need.

Pricing & Value

Tie

Both tools lack transparent pricing information, requiring direct contact with the vendor. Without specific cost details for either, it is impossible to conduct a meaningful comparison of their respective value propositions.

Enterprise Readiness

AliveCor QT Service

Both tools demonstrate strong foundational enterprise readiness with FDA clearance, HIPAA compliance, and BAA. However, AliveCor QT Service explicitly highlights API availability for integration with EHR and other enterprise platforms, suggesting a more robust and documented approach to system interoperability.

Innovation

Tie

Both tools represent significant innovation in their respective domains by leveraging AI and deep learning to derive critical physiological insights from real-world patient data. AliveCor focuses on immediate cardiac safety, while Prolaio targets long-term cardiovascular risk assessment, each pushing the boundaries of remote patient monitoring and AI diagnostics.

Support & Docs

AliveCor QT Service

AliveCor, as a more established company with a broader product line, offers a well-developed support infrastructure, including a comprehensive support portal and professional resources. Specific documentation and support details for the prolaio eVO2peak Module are less readily apparent, suggesting AliveCor likely provides more extensive and accessible support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AliveCor QT Service	prolaio eVO2peak Module
Tool Name	AliveCor QT Service	prolaio eVO2peak Module
Company	AliveCor	Prolaio
Primary Measurement/Function	Instant, accurate QT and QTc interval measurements	Estimates peak oxygen consumption (eVO2peak)
Input Data/Devices	AliveCor 6-Lead ECGs (e.g., KardiaMobile 6L)	Demographic data, single-lead ECG, triaxial accelerometry from qualified third-party FDA-cleared wearable medical sensors
Key Technology	AI and deep neural networks for ECG analysis	Locked deep-learning model for eVO2peak estimation, proprietary algorithms

Videos

Demos, reviews, and walkthroughs featuring AliveCor QT Service and prolaio eVO2peak Module.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical application of AliveCor QT Service versus prolaio eVO2peak Module?

The AliveCor QT Service is designed to provide instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, primarily for assessing cardiac safety and informing medication prescribing decisions. In contrast, the prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) using real-world patient data, serving as an adjunctive aid in clinical evaluation for cardiovascular research and care.

What types of patient data and devices are required for each tool?

The AliveCor QT Service analyzes ECGs specifically from AliveCor 6-Lead ambulatory ECG devices, such as the KardiaMobile 6L. The prolaio eVO2peak Module utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs, which are processed from qualified third-party FDA-cleared wearable medical sensors.

How do these tools integrate into existing clinical workflows or electronic health records (EHRs)?

The AliveCor QT Service integrates with the KardiaStation app and KardiaPro portal, and offers an API for integration with EHR, SDK, CRM, EDC, and PSP platforms. The prolaio eVO2peak Module is a cloud-based software that processes remote sensor data, with documentation including instructions for integration and intended context of use.

What is the intended role of each tool in clinical decision-making?

AliveCor QT Service is for prescription (Rx) use only by qualified healthcare professionals to assess cardiac safety and inform medication prescribing decisions. The prolaio eVO2peak Module provides information as an adjunctive aid in the clinical evaluation of patients, not intended as a diagnostic or for active patient monitoring.

Which medical specialties are these tools primarily designed to serve?

The AliveCor QT Service is primarily for Cardiology, Emergency Medicine, and Internal Medicine. The prolaio eVO2peak Module is designed for Cardiology, Physical Medicine & Rehab, and Sports Medicine.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring AliveCor QT Service or prolaio eVO2peak Module

Backers

Who funded each tool's parent company.